Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries

We are analyzing https://link.springer.com/article/10.1007/s002620050586.

Title:
Tumor-induced immune dysfunction | Cancer Immunology, Immunotherapy
Description:
Immune system-based approaches for the treatment of malignant disease over the past decades have often focused on cytolytic effector cells such as cytotoxic T lymphocytes (CTL), and natural killer (NK) cells. It has also been demonstrated that tumor-bearing mice can be cured using a wide variety of approaches, some of which involve cytokine-mediated enhancement of CTL and NK cell activity. However, the apparent success in mice stands in contrast to the current situation in the clinic, wherein only a minority of patients have thus far benefited from CTL- or NK cell-based antitumor approaches. The underlying causes of tumor-associated immune suppression of CTL and NK cell activity are discussed, and features of interest shared with HIV infection, leprosy, and rheumatoid arthritis are also be mentioned. Remarkable and very recent observations have shed more light upon the causes of dysfunctional alterations in CTL and NK cells often associated with these diseases, that in turn have suggested new immunotherapeutic approaches for cancer and infectious disease.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, article, cells, immunotherapy, ctl, privacy, cookies, content, immune, cell, information, publish, research, search, approaches, access, data, log, journal, immunology, kiessling, wasserman, horiguchi, discover, karolinska, springer, optional, personal, parties, policy, find, track, tumorinduced, dysfunction, cite, rolf, ken, shigetoshi, koji, kono, jan, sjöberg, pavel, pisa, max, petersson, explore, disease, cytotoxic, natural,

Topics {✒️}

tumor-induced immune dysfunction nci-frederick cancer research month download article/chapter article cancer immunology involve cytokine-mediated enhancement nk cell activity nk cell biology cytolytic effector cells privacy choices/manage cookies full article pdf natural killer cells nk cells immunotherapy aims tumor-bearing mice nk cell european economic area ks-ringen r8 conditions privacy policy accepting optional cookies jan sjöberg related subjects sweden e-mail check access instant access yamanashi-ken journal finder publish article kiessling current situation 20 march 1999 / accepted article log ken wasserman immune suppression koji kono article cite privacy policy cancer personal data cells cytotoxic immunotherapeutic approaches books a optional cookies manage preferences natural killer development center nk subscription content similar content data protection karolinska hospital

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tumor-induced immune dysfunction
         description: Immune system-based approaches for the treatment of malignant disease over the past decades have often focused on cytolytic effector cells such as cytotoxic T lymphocytes (CTL), and natural killer (NK) cells. It has also been demonstrated that tumor-bearing mice can be cured using a wide variety of approaches, some of which involve cytokine-mediated enhancement of CTL and NK cell activity. However, the apparent success in mice stands in contrast to the current situation in the clinic, wherein only a minority of patients have thus far benefited from CTL- or NK cell-based antitumor approaches. The underlying causes of tumor-associated immune suppression of CTL and NK cell activity are discussed, and features of interest shared with HIV infection, leprosy, and rheumatoid arthritis are also be mentioned. Remarkable and very recent observations have shed more light upon the causes of dysfunctional alterations in CTL and NK cells often associated with these diseases, that in turn have suggested new immunotherapeutic approaches for cancer and infectious disease.
         datePublished:
         dateModified:
         pageStart:353
         pageEnd:362
         sameAs:https://doi.org/10.1007/s002620050586
         keywords:
            Key words Immunosuppression
            Cancer
            Tolerance
            Zeta chains
            CTL
            NK cells
            Oncology
            Immunology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:48
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rolf Kiessling
               affiliation:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                     address:
                        name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ken Wasserman
               affiliation:
                     name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA
                     address:
                        name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , US
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shigetoshi Horiguchi
               affiliation:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                     address:
                        name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koji Kono
               affiliation:
                     name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan
                     address:
                        name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , JP
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jan Sjöberg
               affiliation:
                     name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden
                     address:
                        name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , SE
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pavel Pisa
               affiliation:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                     address:
                        name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Max Petersson
               affiliation:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                     address:
                        name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tumor-induced immune dysfunction
      description: Immune system-based approaches for the treatment of malignant disease over the past decades have often focused on cytolytic effector cells such as cytotoxic T lymphocytes (CTL), and natural killer (NK) cells. It has also been demonstrated that tumor-bearing mice can be cured using a wide variety of approaches, some of which involve cytokine-mediated enhancement of CTL and NK cell activity. However, the apparent success in mice stands in contrast to the current situation in the clinic, wherein only a minority of patients have thus far benefited from CTL- or NK cell-based antitumor approaches. The underlying causes of tumor-associated immune suppression of CTL and NK cell activity are discussed, and features of interest shared with HIV infection, leprosy, and rheumatoid arthritis are also be mentioned. Remarkable and very recent observations have shed more light upon the causes of dysfunctional alterations in CTL and NK cells often associated with these diseases, that in turn have suggested new immunotherapeutic approaches for cancer and infectious disease.
      datePublished:
      dateModified:
      pageStart:353
      pageEnd:362
      sameAs:https://doi.org/10.1007/s002620050586
      keywords:
         Key words Immunosuppression
         Cancer
         Tolerance
         Zeta chains
         CTL
         NK cells
         Oncology
         Immunology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:48
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rolf Kiessling
            affiliation:
                  name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                  address:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ken Wasserman
            affiliation:
                  name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA
                  address:
                     name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , US
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shigetoshi Horiguchi
            affiliation:
                  name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                  address:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koji Kono
            affiliation:
                  name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan
                  address:
                     name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , JP
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jan Sjöberg
            affiliation:
                  name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden
                  address:
                     name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , SE
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pavel Pisa
            affiliation:
                  name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                  address:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Max Petersson
            affiliation:
                  name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
                  address:
                     name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:48
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
      address:
         name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
         type:PostalAddress
      name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA
      address:
         name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , US
         type:PostalAddress
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
      address:
         name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
         type:PostalAddress
      name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan
      address:
         name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , JP
         type:PostalAddress
      name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden
      address:
         name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , SE
         type:PostalAddress
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
      address:
         name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
         type:PostalAddress
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
      address:
         name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rolf Kiessling
      affiliation:
            name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
            address:
               name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
               type:PostalAddress
            type:Organization
      name:Ken Wasserman
      affiliation:
            name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA
            address:
               name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , US
               type:PostalAddress
            type:Organization
      name:Shigetoshi Horiguchi
      affiliation:
            name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
            address:
               name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
               type:PostalAddress
            type:Organization
      name:Koji Kono
      affiliation:
            name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan
            address:
               name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , JP
               type:PostalAddress
            type:Organization
      name:Jan Sjöberg
      affiliation:
            name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden
            address:
               name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , SE
               type:PostalAddress
            type:Organization
      name:Pavel Pisa
      affiliation:
            name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
            address:
               name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
               type:PostalAddress
            type:Organization
      name:Max Petersson
      affiliation:
            name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195
            address:
               name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
      name:LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , US
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
      name:Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , JP
      name:Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , SE
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
      name:Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: [email protected]; Fax: +46-8-309195, , SE
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(37)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

3.71s.